Live birth following double-factor pre-implantation genetic diagnosis for both reciprocal translocation and alpha-thalassaemia

Lee, Vivian CY; Chow, Judy F.C.; Lau, Esther Yuet Ying; Yeung, William S.B.; Ng, Ernest H.Y.

doi:10.12809/hkmj134087

Cited by 5 publications

(1 citation statement)

References 8 publications

(7 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Nowadays, it is no longer rare for centres to be confronted with applicants asking for such 'combination PGT' (cPGT-M/SR). Two case reports describe cPGT-M for Tay-Sachs and Gaucher disease and a cPGT-M/SR for a reciprocal translocation and alfathalassemia (Altarescu et al, 2007;Lee et al, 2014). Kuliev et al (2014) listed a small series of cPGT-M treatments including combinations of single-gene disorders like Charcot-Marie-Tooth and Fabry disease; HBOC (hereditary breast and ovarian cancer) and SMA (spinal muscular atrophy) and HBOC and MEN1 (multiple endocrine neoplasms type 1).…”

Section: Introductionmentioning

confidence: 99%

Preimplantation genetic testing for more than one genetic condition: clinical and ethical considerations and dilemmas

et al. 2019

View full text Add to dashboard Cite

published version features the final layout of the paper including the volume, issue and page numbers. Link to publication General rightsCopyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal.If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the "Taverne" license above, please follow below link for the End User

show abstract

Section: Introductionmentioning

confidence: 99%